Skip to main content
OpenTrials
Completed

NCT Number: NCT01474980

Pregnancy Outcomes in Congenital Myasthenie Syndrome

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The aim of this study is to better understand the action of hormonal factors that are presumably incriminated for the fluctuation of the disease. The investigators would also like to better adress the issues of women with Congenital Myasthenic Syndrome, who desire a pregnancy : the possibility of decompensation, the problems that can arise during the course of the childbearing, the risk of foetal malformations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult women
  • Congenital myastenic syndrome genetically confirmed or with clinical compatible and electrophysiological evidence
  • Written consent

Exclusion criteria

  • Neurological or general pathology occurs significantly with the initiation and conduct of a pregnancy.

Sponsors and collaborators

Lead sponsor

Institut de Myologie, France

Other

Collaborators

  • Assistance Publique - Hôpitaux de Paris

Registry information

Official study title

Retrospective Study :Describe the Changes of the Disease in Many Cases Likely to Aggravate.

Acronym: POCoMS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Nov 18, 2011
Registry last updated
Nov 18, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.